SA

Selvakumar Abathsahayam

Director DIN 03218733
DIN 03218733 First appointment Oct 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Selvakumar Abathsahayam

Data last updated:

Selvakumar Abathsahayam was a Whole-Time Director at Kalaangi Bio-Sciences Private Limited (from 2013) and Director at Renlabs Pharma Private Limited (from 2010).

DIN 03218733
First Appointment 21 Oct 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director28 Nov 20132013Strike Off
Renlabs Pharma Private Limited U24230TN2010PTC077775
Director21 Oct 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kalaangi Bio-Sciences Private Limited
Renlabs Pharma Private Limited
Premium access

Shareholding and investment profile for Selvakumar Abathsahayam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Selvakumar Abathsahayam

Selvakumar Abathsahayam was first appointed on 21 Oct 2010 as Director at Renlabs Pharma Private Limited. The most recent appointment on record is 28 Nov 2013 at Kalaangi Bio-Sciences Private Limited.

Selvakumar Abathsahayam held 2 earlier board appointments: Kalaangi Bio-Sciences Private Limited (Whole-Time Director, from 28 Nov 2013); Renlabs Pharma Private Limited (Director, from 21 Oct 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available